One of the physicians specializing in sickle cell disease says that pain is an undeniable focal point for patients with the condition but it is not the best focus for drug development. Rather scientists need to get back to the crux of the disease affecting 1 in 500 black Americans and find better ways to prevent the hallmark sickling that impedes red blood cells' oxygen delivery, damaging blood vessel walls and organs along the way, said Dr. Abdullah Kutlar, Director ...Sunday, 21 April 2013
Focus for Sickle Cell Science Should be Development of Anti-Sickling Therapies
One of the physicians specializing in sickle cell disease says that pain is an undeniable focal point for patients with the condition but it is not the best focus for drug development. Rather scientists need to get back to the crux of the disease affecting 1 in 500 black Americans and find better ways to prevent the hallmark sickling that impedes red blood cells' oxygen delivery, damaging blood vessel walls and organs along the way, said Dr. Abdullah Kutlar, Director ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment